GL1X · GenesisL1 explorer

UniProt P14778

Interleukin-1 receptor type 1 (P14778)

Interleukin-1 receptor type 1 (UniProt P14778): 10 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound, 70 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P14778
Protein
Interleukin-1 receptor type 1
Experimental structures
10
Predicted models
1
Ligands
2
Pockets
70 · 10 records with a druggable one

Structures

11 records of P14778 in the MolNFT archive: 10 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1G0YIl-1 receptor type 1 complexed with antagonist peptide AF10847x-ray diffractionR—4 (best 0.75)
1G0YIl-1 receptor type 1 complexed with antagonist peptide AF10847x-ray diffractionR—4 (best 0.75)
1IRAComplex of the interleukin-1 receptor with the interleukin-1 receptor antagonist (IL1RA)x-ray diffractionYNAG5 (best 0.72)
1IRAComplex of the interleukin-1 receptor with the interleukin-1 receptor antagonist (IL1RA)x-ray diffractionYNAG5 (best 0.72)
1ITBType-1 interleukin-1 receptor complexed with interleukin-1 betax-ray diffractionB—5 (best 0.73)
1ITBType-1 interleukin-1 receptor complexed with interleukin-1 betax-ray diffractionB—5 (best 0.73)
4DEPStructure of the IL-1b signaling complexx-ray diffractionB, ENAG15 (best 0.79)
4DEPStructure of the il-1B signaling complexx-ray diffractionB, ENAG15 (best 0.79)
4GAFCrystal structure of EBI-005, a chimera of human IL-1beta and IL-1Ra, bound to human Interleukin-1…x-ray diffractionBNAG, NA6 (best 0.75)
4GAFCrystal structure of ebi-005, a chimera of human il-1BETA and il-1RA, bound to human interleukin-1…x-ray diffractionBNAG, NA6 (best 0.75)
P14778AlphaFold monomer V2.0 prediction for interleukin-1 receptor type 1 (P14778)predictedA——

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 6 records
  • NA · Sodium ion · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.